Subscribe

 Regulatory Overview: Balancing Statutory and Regulatory Criteria for Evaluation of Bulk Drug Substances Nominated for Use Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Compounding with Dietary Supplements

Presentation and Speech September 12, 2018

Related News & Insights